Oral Bioavailability and Pharmacokinetics of Trovafloxacin in Patients with AIDS
Trovafloxacin pharmacokinetics were evaluated in 12 subjects with AIDS. By using a randomized design, single 200-mg doses of oral trovafloxacin and intravenous alatrofloxacin were administered. The mean absolute bioavailability was 91%. The pharmacokinetics of trovafloxacin when administered orally...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1999
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89603/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10582898/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.12.3005 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
